Bipolar Clinical Trial
— LicavalgeneOfficial title:
Genetic Association Study Between Single Nucleotide Polymorphisms (SNPs) and Cognitive Performance in Young Bipolar Type I Patients: LICAVALGENE
This is a genetic association study of cognitive impairment in young bipolar disease type I patients without medications in mania, depression, hypomania or mixed states.
Status | Enrolling by invitation |
Enrollment | 80 |
Est. completion date | March 2012 |
Est. primary completion date | March 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 35 Years |
Eligibility |
Inclusion Criteria: - BD type 1 - non euthymia - 18-35 y.o. Exclusion Criteria: - pregnancy - organic disease - use of drugs - schizophrenia - mental retardation - illiterate |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Brazil | Institute of Psychiatry, School of Medicine University of Sao Paulo | Sao Paulo |
Lead Sponsor | Collaborator |
---|---|
University of Sao Paulo |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cognitive deficits in BD patients are associated with COMT, ApoE and BDNF polymorphisms | 18 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02133170 -
"Mindfulness vs Psychoeducation in Bipolar Disorder"
|
N/A | |
Completed |
NCT02189057 -
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression
|
N/A | |
Completed |
NCT00666432 -
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
|
||
Completed |
NCT00300820 -
Perspectives of Individuals With Bipolar Disorder and Siblings of Individuals With Bipolar Disorder; A Telephone Interview Study
|
N/A | |
Completed |
NCT02184767 -
Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication
|
Phase 1 | |
Terminated |
NCT01131559 -
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
|
Phase 3 | |
Recruiting |
NCT01047215 -
Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine
|
Phase 4 |